Feedback / Questions
Cosentyx (secukinumab) - Novartis
Cosentyx: Completion of P3 trial (NCT03031782) for psoriatic arthritis in 2021
(Novartis)
-
Oct 22, 2019 -
Q3 2019 Results
Trial completion date
https://www.novartis.com/sites/www.novartis.com/files/q3-2019-ir-presentation.pdf
Oct 22, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious